Multiplex Assay Kit for Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay)

EPO-R

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-94 88
EDTA plasma(n=5) 91-105 101
heparin plasma(n=5) 90-98 93
sodium citrate plasma(n=5) 94-104 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 85-97% 80-90% 88-96% 98-105%
EDTA plasma(n=5) 91-98% 78-96% 93-101% 90-104%
heparin plasma(n=5) 88-102% 82-94% 97-105% 96-105%
sodium citrate plasma(n=5) 81-90% 97-105% 83-103% 94-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:EPOR) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
J Appl Physiol (1985). Decreased plasma soluble erythropoietin receptor in high-altitude excessive erythrocytosis and Chronic Mountain Sickness Pubmed:25324511
J Appl Physiol Plasma soluble erythropoietin receptor is decreased during sleep in Andean highlanders with Chronic Mountain Sickness Pubmed:27125843
FASEB JOURNAL High-altitude hypoxia decreases plasma erythropoietin soluble receptor (sEpoR) concentration in humans
high altitude medicine & biology High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders Pubmed: 31977247
Physiology Reports Effect of exercise training in rats exposed to chronic hypoxia: Application for Monge's disease 33904648
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA027Hu03 Recombinant Erythropoietin Receptor (EPOR) Positive Control; Immunogen; SDS-PAGE; WB.
RPA027Hu01 Recombinant Erythropoietin Receptor (EPOR) Positive Control; Immunogen; SDS-PAGE; WB.
RPA027Hu02 Recombinant Erythropoietin Receptor (EPOR) Positive Control; Immunogen; SDS-PAGE; WB.
PAA027Hu01 Polyclonal Antibody to Erythropoietin Receptor (EPOR) WB; IHC; ICC; IP.
PAA027Hu02 Polyclonal Antibody to Erythropoietin Receptor (EPOR) WB; IHC; ICC; IP.
LAA027Hu81 FITC-Linked Polyclonal Antibody to Erythropoietin Receptor (EPOR) WB; IHC; ICC; IF.
LAA027Hu71 Biotin-Linked Polyclonal Antibody to Erythropoietin Receptor (EPOR) WB; IHC; ICC.
MAA027Hu22 Monoclonal Antibody to Erythropoietin Receptor (EPOR) WB; IHC; ICC; IP.
MAA027Hu21 Monoclonal Antibody to Erythropoietin Receptor (EPOR) WB; IHC; ICC; IP.
SEA027Hu ELISA Kit for Erythropoietin Receptor (EPOR) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA027Hu Multiplex Assay Kit for Erythropoietin Receptor (EPOR) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.